Helius Medical Technologies Inc. (HSDT) Total Business Assets
Helius Medical (HSDT) bases its technological superiority on the unique PoNS system, which holds official innovation status, although slow insurance reimbursement adoption limits expansion. The business focuses on developing wearable devices for the rehabilitation of individuals with multiple sclerosis or stroke consequences. This price chart, illustrating trading dynamics with total assets at 91.97, complements environmental data: the company is implementing energy-efficient solutions to reduce its environmental impact.
Analytical breakdowns for heliusmedical.com (HSDT)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Helius Medical|HSDT - Long-Term Debt to Equity|Current Liabilities to Capital Helius Medical Technologies|HSDT - Company Aggregate Debts|Debt to Net Assets Ratio Helius Medical Technologies, Inc.|HSDT - Company Long-Term Debts|Short-Term Debt Helius Medical Technologies
Analysis of all company metrics:Helius Medical
The scaling of Helius Medical (HSDT) depends directly on the sales expansion of PoNS stimulators for the rehabilitation of stroke patients. Monitoring total assets via ROA reflects the dynamics of resources formed through equity and debt, allowing for a determination of whether the expansion of the asset base is sustainable or if it creates a critical debt load that threatens the issuer's financial stability.
Competing companies
BIIB (biogen.com) - Aggregate Business Assets|Aggregate Company Assets Neurocrine Biosciences, Inc. (NBIX)|Total Business Assets Regencell Bioscience Ltd|Axsome Therapeutics Inc - Company Total Assets|Company Assets ACADIA Corp ACAD|Cumulative Company Assets XENE (Xenon Pharmaceuticals)|vikingtherapeutics.com - Company Total Assets|Aggregate Company Assets Supernus (SUPN)|CPRX: Aggregate Asset Value|Aggregate Company Assets DNLI|Harmony Corp (HRMY) - Company Assets|BHVN - Company Total Assets|Aggregate Asset Value amylyx.com|Trevi Therapeutics, Inc. - Company Total Assets|Company Assets PRAX (Praxis Precision Medicines Inc)|Aggregate Company Assets Anavex Corp AVXL|Aggregate Company Assets CeriBell EEG CBLL|Company Total Assets PRTA (Prothena Corporation plc)|Alector, Inc. (ALEC) - Company Total Asset Base|ANNX: Cumulative Company Assets|OMER (Omeros) - Company Total Assets|NGNE: Aggregate Company Assets|Company Total Asset Base AC Immune Inc (ACIU)|Voyager Therapeutics (VYGR) - Cumulative Company Assets|Aggregate Asset Value NMRA (neumoratx.com)|Scilex - Aggregate Company Assets|Cumulative Company Assets Tevogen Bio Holdings Inc. TVGN|ACOG (Alpha Cognition Corp) - Company Total Assets|CGTX - Company Assets|Company Total Assets Inhibikase Therapeutics|cassavasciences.com (SAVA) - Total Business Assets|ASRT: Company Total Assets|Company Total Asset Base Coya|Company Total Assets VTGN (Vistagen Therapeutics)|Cumulative Company Assets ovidrx.com (OVID)|Company Total Assets ABOS (Acumen Pharmaceuticals)|cervomed.com - Company Total Assets|ATHE - Aggregate Company Assets|CLNN - Aggregate Company Assets|Company Total Assets pepgen.com PEPG|JUNS (Jupiter Neurosciences, Inc.) - Aggregate Asset Value|RLMD: Aggregate Company Assets|Company Total Asset Base annovisbio.com|Company Total Assets Grace Therapeutics, Inc. GRCE|Total Business Assets Firefly Neuroscience, Inc. AIFF|Cumulative Company Assets Klotho Neurosciences (KLTO)|NeuroSense Therapeutics Ltd - Aggregate Business Assets|Reviva Pharmaceuticals (RVPH) - Aggregate Company Assets|MTVA - Total Business Assets|Company Total Assets NRXS|Company Assets Passage Bio|NEUP (Neuphoria Therapeutics, Inc.) - Cumulative Company Assets|Company Total Assets NERV|Athira Pharma, Inc. (ATHA) - Aggregate Company Assets|Aggregate Asset Value ADXN (addextherapeutics.com)|ALZN: Aggregate Company Assets|Company Assets Cyclerion Therapeutics Inc. CYCN|Company Total Assets Protagenic (PTIX)|KTTA - Aggregate Asset Value|Company Total Assets CRGT|ATXI (avenuetx.com) - Company Assets|Aggregate Company Assets BrainStorm Cell Therapeutics|Aggregate Company Assets Cara Therapeutics Inc.|CHRO (Chromocell Therapeutics Corporation) - Company Total Assets|Company Total Asset Base eliemtx.com ELYM|Cumulative Company Assets ITCI (Intra-Cellular Therapies, Inc.)|longboardpharma.com - Company Total Assets|Aggregate Company Assets MRNS (Marinus Pharmaceuticals, Inc.)|NKGen Biotech Inc (NKGN) - Company Total Asset Base|Cumulative Company Assets NeuroBo NRBO|SAGE (Sage Therapeutics Inc) - Aggregate Asset Value|Aggregate Company Assets SNPX|Cumulative Company Assets trevena.com|Vigil Neuroscience - Company Total Assets|Company Assets anewmeds.com (WENA)|CERE - Company Total Assets